K aposi's sarcoma-associated herpesvirus (KSHV) is etiologically linked to several malignancies including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL) 1 . KSHV lifecycle has latent and lytic replication phases 1 . KSHV establishes latent infection in host cells replicating as an episome in the nucleus and expressing only several latent genes. Latently infected cells can be reactivated into lytic replication expressing most viral genes and producing virions. In KS, most tumour cells are latently infected by KSHV, indicating an essential role of latent infection in this malignancy 1 . However, a few KSHV-infected tumor cells undergo spontaneous lytic replication contributing to tumor progression. Defining mechanisms regulating KSHV latent and lytic infection is essential for understanding KSHV lifecycle and pathogenesis of KSHVassociated malignancies. Despite intensive studies, these molecular events remain ill-defined. N 6 -methyladenosine (m 6 A), the most prevalent modification on messenger RNA, was identified in the 1970 s 2 . The advent of methylated RNA immunoprecipitation followed by sequencing (m 6 A-seq) technology has enabled transcriptome-wide mapping of m 6 A 3,4 . However, the recent development of another technique, m 6 A individualnucleotide-resolution cross-linking and immunoprecipitation, which allows precise transcriptome-wide mapping of m 6 A and another modification, N 6 ,2′ -O-dimethyladenosine (m 6 Am) found mostly on the first nucleotide of mRNA, has revealed that the original m 6 A-seq mapping technique, in fact, detects both m 6 A and m 6 Am (m 6 A/m) 5 .
Most KSHV transcripts are methylated during viral lytic replication. We further mapped the KSHV m 6 A/m epitranscriptome during lytic replication. Treatment with doxycycline efficiently triggers KSHV lytic replication in KiSLK and BCBL1-R cells 34, 35 . Upon induction of lytic replication, m 6 A/m-related enzymes remained largely unchanged at both mRNA and protein levels in KiSLK cells; however, they declined at both mRNA and protein levels in BCBL1-R cells, with ALKBH5, YTHDF1 and YTHDF2 proteins having the sharpest decreases 24 h after induction ( Supplementary  Fig. 1c,d) .
Purified mRNA from three biological replicates of lytically induced cells at 24 h and 48 h from KiSLK cells and at 48 h from BCBL1-R cells was subjected to m 6 A/m mapping. Again, we observed highly consistent results among three biological replicates ( Supplementary Fig. 2 ). During viral lytic replication, transcripts of most KSHV genes were expressed ( Fig. 2a ) with increase in reads by 76-and 119-fold at 24 h and 48 h, respectively, in KiSLK cells, and by 46-fold at 48 h in BCBL1-R cells. We detected abundant m 6 A/m peaks on transcripts after lytic induction ( Fig. 2a , Supplementary  Table 2 ).
First, we observed gains of additional m 6 A/m peaks on vFLIP, vCyclin and LANA latent transcripts during lytic replication in both KiSLK and BCBL1-R cells, particularly new m 6 A/m peaks in LANA central and N-terminal regions, which were absent during latency (Fig. 2b) . The latent locus contained many immunoprecipitation (IP) reads spanning its entire region, which might be due to multiple m 6 A/m bases that could not be sufficiently resolved by this approach. Second, we examined the RTA locus, which expresses multiple transcripts coding for RTA, an early protein K8 and a late protein K8.1 (Fig. 2b) . Because of the RTA cassette, reads from the region contained those from the cassette and those endogenously transcribed. m 6 A/m peaks were detected on the N and C termini and the central region of RTA in lytic KiSLK cells, but only on the central and C-terminal regions in lytic BCBL1-R cells. Interestingly, the expression of K8.1 was already robust in latent BCBL1-R cells compared to KiSLK cells and was significantly increased in both lytic BCBL1-R and KiSLK cells. An m 6 A/m peak was detected on the C-terminal region of K8.1 transcripts. Third, we observed other conserved m 6 A/m peaks between the two cell lines on transcripts of ORF-K1, ORF4, ORF-K3, ORF8, ORF11 and ORF57 (Fig. 2b) . Numerous m 6 A/m peaks were cell type specific. For example, the m 6 A/m peak on the ORF6 transcript was present in latent and lytic KiSLK cells but not in BCBL1-R cells. Fourth, all the selected m 6 A/m peaks were confirmed by MeRIP-qPCR ( Fig. 2c ).
Compared to latent KiSLK cells, there were significant gains in methylated viral genes in lytic KiSLK cells, reflecting the increased expression levels of viral genes (Fig. 2d, left) . In contrast, similar methylated viral genes were observed in latent and lytic BCBL1-R cells, reflecting high spontaneous lytic replication in these latent cells (Fig. 2d, right) . Importantly, most of the methylated viral genes at 48 h lytic replication were conserved between KiSLK and BCBL1-R cells (Fig. 2e ). The abundance of m 6 A/m peaks on viral transcripts during lytic replication and their conserved nature between two cell types point to an important role of m 6 A/m modifications in KSHV lytic replication.
YTHDF2 inhibits KSHV lytic replication by promoting degradation of viral transcripts.
Since the functions of m 6 A/m modifications are executed by the 'reader' proteins, we investigated their roles in KSHV lytic replication. Knockdown of YTHDF1, YTHDC1 or YTHDC2 had no significant or consistent effect on viral lytic replication ( Supplementary Fig. 3a-c) . While
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knockdown of YTHDF3 reduced viral lytic replication by 40% and 70% with the two siRNAs, respectively, examination of viral transcripts and proteins did not yield consistent results ( Supplementary  Fig. 3d,e ). In contrast, we observed consistent effect of YTHDF2 knockdown on KSHV lytic replication. Efficient knockdown of YTHDF2 was achieved 2 days after siRNA transfection ( Fig. 3a,b ), which consistently led to a fourfold increase in viral production ( Fig. 3c ). Accordingly, we observed two-to sixfold increases in RTA, ORF57, ORF-K8 and ORF65 lytic transcripts ( Fig. 3d ), which also led to increases in their proteins (Fig. 3e ). Overexpression of YTHDF2 led to decreased viral production and reduced levels of viral proteins ( Fig. 3f-h) . RNA-binding protein immunoprecipitation and reverse transcription quantitative real-time PCR (RIP-qPCR) showed that YTHDF2 strongly bound to RTA, vIL6, ORF-K8 and ORF57 lytic transcripts and, to lesser extents, LANA, PAN RNA and ORF65 transcripts (Fig. 3i ).
Since YTHDF proteins enhance degradation and deadenylation of m 6 A/m-containing transcripts 21, 22 , we examined the half-lives of cellular transcripts with and without YTHDF2 knockdown. As expected, the presence of m 6 A/m shortened the half-lives of transcripts ( Supplementary Fig. 4a ). Interestingly, YTHDF2 knockdown did not alter the negative effect of m 6 A/m on mRNA stability, though all the transcripts became more stable ( Supplementary Fig. 4b ). Hence, YTHDF2 knockdown increased the half-lives of cellular transcripts ( Supplementary  Fig. 4c ). These results could be due to other reader proteins such as YTHDF1, YTHDF3 and YTHDC2, which redundantly mediate m 6 A/m-dependent mRNA stability 21, 22, 26 . These reader proteins might compensate its function following YTHDF2 knockdown. Indeed, the YTHDF proteins have been reported to redundantly mediate the genome stability of several RNA viruses, including HCV, ZIKA and HIV-1 22, [28] [29] [30] . The fact that we detected a consistent effect of single knockdown only in YTHDF2 but not other reader proteins on KSHV lytic replication could be due to its relatively higher expression level in cells 20 . We hypothesized that knockdown of YTHDF2 would prolong the half-lives of viral transcripts, leading to their accumulation. Indeed, silencing YTHDF2 caused an increase of the overall half-life 
ORF72.1_4 were examined by RT-qPCR and western blotting, respectively, at day 3 after induction of lytic replication. For virion production, lytic siCl cells were used as '1' for comparison. Experiments were independently repeated three times, and results are presented as mean ± s.d. from the three experiments (b-d), except (a,e) where representative results from one experiment are presented. NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001. f, YTHDF2 overexpression in KiSLK cells 2 days after lentiviral transduction. g,h, KSHV virions in culture supernatant were quantified by qPCR (g) and levels of viral proteins (h) were examined by western blotting at day 3 after induction of lytic replication. For virion production, lytic vector cells were used as '1' for comparison. Experiments were independently repeated three times and results are presented as mean ± s.d. from the three experiments (g), except (f,h) where representative results from one experiment are presented. i, KiSLK cells overexpressing Flag-YTHDF2 were induced for lytic replication, and cell lysate was collected at 48 h to detect YTHDF2 binding of viral RNAs by RIP-qPCR. SON and MALAT1 are cellular positive and negative controls, respectively. Experiments were independently repeated twice, and results are presented as mean from the two experiments. j, Lifetimes of KSHV transcripts were measured in cells transfected with YTHDF2 siRNA (siY2-1) or a control siRNA (siCl). Results are from two independent experiments. k, Quantification of levels of viral and cellular transcripts following treatment with actinomycin D at day 3 after induction of lytic replication in KiSLK cells transfected with an siY2-1 or an siCl. The half-lives of the transcripts in hours were calculated. Experiments were independently repeated twice, and results are presented as mean ± s.d. from the two experiments. l, Fold changes of KSHV transcripts in cells transfected with siY2-1 and siCl at 0 h and 16 h post-actinomycin D treatment sorted by transcript class. Results are from two independent experiments. IE, immediate-early.
of KSHV transcripts ( Fig. 3j ). Quantitative PCR with reverse transcription (RT-qPCR) confirmed that the half-lives of LANA, ORF57, ORF59, ORF-K8 and ORF65 transcripts were increased by an average of ~1.5-fold ( Fig. 3k ). The half-life of PAN RNA, a long non-coding RNA localized to the nucleus, was not significantly affected as it might escape YTHDF2-mediated degradation in the cytoplasm. Examination of transcript stability by transcript class showed that latent transcripts coding for LANA, vCyclin and vFLIP, and early transcripts coding for ORF-K8, ORF37 and ORF-K6, had the largest increases in half-life following YTHDF2 knockdown, whereas immediate-early transcripts were least affected ( Fig. 3l ). Taken together, our results indicated that YTHDF2 might inhibit KSHV lytic replication by promoting the degradation of viral lytic transcripts. It is possible that YTHDF2 might act as a cellular defence mechanism to inhibit viral replication by restricting the expression of viral transcripts.
Cellular m 6 A/m epitranscriptome is reprogrammed during KSHV latent infection.
To determine whether KSHV modulates the cellular epitranscriptome, we examined the four pairs of uninfected and KSHV latently infected cells ( Supplementary Fig. 1a ). We included BCBL1-R because of its unique B-cell origin representing PEL. The three biological replicates showed excellent m 6 A/m-seq overlaps ( Supplementary Table 3 ). First, we compared the uninfected cells and identified 3,233 methylated genes that were conserved among TIME, MSC, MM and iSLK cells, accounting for about 40-60% of methylated genes in each cell type ( Supplementary  Fig. 5a ). These results are expected as the m 6 A epitranscriptome is conserved among organisms. An m 6 A/m peak in Dicer1 and another in JunB as well as an unmethylated Dicer1 region conserved among all four cell types were selected and confirmed by MeRIP-qPCR ( Supplementary Fig. 6a,b ). Among the three human cell types, another 2,685 methylated genes (34-35%) were conserved, indicating that over 74-76% of the methylated genes were conserved among the human cells. MM cells had the highest number of uniquely methylated genes (1, 156) , indicating that the effect of species was stronger than cell type in specifying m 6 A/m methylation pattern. MM and MSC cells also shared many methylated genes (3, 887) , which could be attributed to both being primary precursor cells. Further clustering analysis confirmed the results, and identified conserved and specific m 6 A/m patterns among these cells ( Supplementary Fig. 5b ).
Next, we compared the methylated genes among the five latently infected cells. Like the uninfected cells, 3,042 methylated genes (33-51% of total genes) were conserved among all types of cells, with more conservation observed among the human cells (5,227 genes or ~56-72% of total genes) ( Fig. 4a ). Of the human cells, BCBL1-R cells had 1,329 uniquely methylated genes compared to 245, 454 and 218 genes in KiSLK, KTIME and KMSC cells, respectively. Clustering analysis confirmed the results, and identified conserved and specific m 6 A/m patterns among these cells ( Supplementary  Fig. 7a ). The same m 6 A/m peaks in Dicer1 and JunB were also confirmed by MeRIP-qPCR ( Supplementary Fig. 6a,b ).
We detected the canonical 'GGAC' m 6 A motif as the most common motif in both uninfected and infected cells, indicating that most m 6 A/m peaks were likely m 6 A peaks (Fig. 4b ). Because this mapping approach cannot directly identify the m 6 Am peaks, we predicted the potential m 6 Am peaks as those ' A's at the beginning of a transcript, containing the m 6 Am conserved BCA motif 5 , and inside exomePeak predicted peaks. Only 7-20% of the peaks were predicted to be putative m 6 Am peaks ( Fig. 4c ).
Because we could not precisely map and distinguish m 6 A and m 6 Am motifs, we analysed the overall m 6 A/m methylated genes without separating both types of peaks. Most methylated genes in uninfected cells remained methylated in KSHV-infected cells (Fig. 4d) . Surprisingly, among the small number of differentially methylated genes, most occurred in 5′ UTR and 3′ UTR (Fig. 4e ). We detected a loss of 5′ UTR methylation and a slight gain of 3′ UTR methylation following KSHV infection in KiSLK, KMSC and KMM cells. The distributions of m 6 A/m in KTIME cells were different from other cells, possibly reflecting their untransformed state. Hence, we focused further analyses on KiSLK, KMSC and KMM cells. Most 5′ UTR hypomethylated and 3′ UTR hypermethylated genes were unique ( Fig. 4f , Supplementary Table 4 ), indicating that m 6 A/m might affect expression or translation of these two groups of genes by different mechanisms. Pathway analysis identified 12 conserved pathways that were 5′ UTR hypomethylated and one conserved pathway that was 3′ UTR hypermethylated across all three pairs of cell types (Fig. 4g ). However, it was obvious that KMSC and KMM cells shared more common 5′ UTR hypomethylated pathways compared to KiSLK cells. KMSC and KMM are primary cells transformed by KSHV, which are excellent models for studying KSHV-induced oncogenesis 36, 37 . Indeed, the top 5′ UTR hypomethylated and 3′ UTR hypermethylated pathways in both KMM versus MM and KMSC versus MSC were broadly related to oncogenic/mitogenic signalling, cytoskeleton and extracellular signalling, endocytosis, loss of contact inhibition, remodelling of adherens junction and cellular adhesion/ invasion, all of which have been implicated in KSHV latency and cellular transformation ( Fig. 4h ). These findings indicated that m 6 A/m modifications might mediate cellular pathways implicated in KSHV-induced cellular transformation. We did not find any correlation of the extent and site of methylation (5′ UTR versus 3′ UTR) with gene expression, suggesting that m 6 A/m might mediate post-transcriptional gene regulation such as splicing, nuclear export or translation.
We investigated the role of m 6 Am in the deregulation of cellular pathways during KSHV latency because of its presence at the start of transcripts, which might contribute to the 5′ UTR hypomethylation. The ratios of the predicted m 6 Am hypermethylated to hypomethylated genes were similar to that of the overall m 6 A/m-containing genes (Fig. 4c ). Pathway analysis of m 6 Am-containing genes did not yield any significantly enriched pathways, indicating a minimal contribution of m 6 Am to the altered oncogenic pathways of 5′ UTR hypomethylation in KSHV latent cells. Table 6 ). Over 83% and 41% of m 6 A/m genes remained methylated when KSHV was reactivated from latency in KiSLK and BCBL1-R cells, respectively ( Fig. 5a ). We confirmed the m 6 A/m peaks in Dicer1 and JunB by MeRIP-qPCR ( Supplementary Fig. 8a,b ). There were more de novo methylated genes in KiSLK cells than BCBL1-R cells (1,138 versus 51) at 48 h after lytic induction ( Fig. 5a ). However, the m 6 A/m epitranscriptomes were clustered by cell type rather than replication status ( Supplementary Fig. 7b ). KiSLK and BCBL1-R cells shared most of the m 6 A/m genes during latent and lytic replication, respectively, albeit we observed small subsets of cell type-specific methylated genes ( Fig. 5b ). Similar to latently infected cells, we detected 'GGAC' as the most common motif in the lytic cells (Fig. 5c ).
KSHV lytic replication induces dynamic changes in cellular m 6 A/m epitranscriptome. We analysed cellular m 6 A/m epitranscriptome during KSHV lytic replication (Supplementary
The most apparent difference between the two cell types was the overall change of m 6 A/m distribution on the transcripts when cells were reactivated from latency, with KiSLK cells being 5′ UTR hypermethylated and 3′ UTR hypomethylated, and BCBL1-R cells being 5′ UTR hypomethylated and 3′ UTR hypermethylated ( Fig. 5d ). Interestingly, of all significantly hypermethylated or hypomethylated genes in both cell types, over 50% of the enriched pathways in BCBL1-R cells overlapped with those in KiSLK cells ( Fig. 5e , Supplementary Table 7 ). The common enriched pathways in both cell types included protein ubiquitination, ERK/MAPK Articles NATURe MicRObiOlOgY signalling, integrin signalling, hypoxia signalling and sumoylation pathways ( Fig. 5f,g) , which have been implicated in KSHV lytic replication [38] [39] [40] [41] .
Since YTHDF2 mediated the degradation of transcripts ( Supplementary Fig. 4c ), we further examined whether it might target genes according to m 6 A/m distribution. We did not find that NATURe MicRObiOlOgY different locations of m 6 A/m on the transcripts affected the halflives of cellular transcripts. Nevertheless, it remains possible that YTHDF2 binding to different positions on the transcripts might differentially affect their stability. Similarly, we investigated m 6 Am during KSHV lytic replication. Only 18% and 16% of peaks were predicted to be m 6 Am in KiSLK and BCBL1-R cells, respectively (Fig. 5h ). Furthermore, few enriched pathways of the hypermethylated and hypomethylated m 6 Am genes overlap with those of m 6 A/m. Hence, m 6 Am had a minimal contribution to the overall m 6 A/m-altered pathways during KSHV lytic replication. Whereas the presence of m 6 A/m shortened the half-lives of cellular transcripts, m 6 Am had only a marginal effect ( Supplementary Fig. 4a ), which was abolished following YTHDF2 knockdown ( Supplementary Fig. 4b ). Hence, YTHDF2 might be involved in m 6 Am regulation of mRNA stability in a small subset of transcripts. Among the viral transcripts, m 6 Am was only predicted to be present in ORF65, ORF66 and ORF67 transcripts in lytic KiSLK cells, and both latent and lytic BCBL1-R cells; and in ORF34, ORF35 and ORF36 transcripts in lytic BCBL1-R cells, indicating that m 6 Am was minimally involved in regulating the stability of viral transcripts.
Discussion
Systematic profiling and characterization have revealed conservation across different kingdoms and diverse cellular functions of m 6 A/m modifications on mRNA 42 . m 6 A has been found on HSV-1 mRNA for decades but the transcript and position containing the modification as well as the underlying function remain unclear 43 . Numerous studies have recently profiled m 6 A/m modifications in genomes of RNA viruses including HIV-1, ZIKV and HCV 22, [27] [28] [29] [30] . We have mapped m 6 A/m modifications on KSHV and cellular transcripts in diverse KSHV-infected cell types undergoing latent and lytic infection. This is the first effort to systematically profile viral and cellular m 6 A/m epitranscriptomes in cells infected by a large DNA virus.
Because of the limited resolution of the technique used in this study, we cannot distinguish the m 6 A and m 6 Am peaks and precisely map their positions. Hence, we have analysed their combined m 6 A/m peaks. Nevertheless, based on the feature of m 6 Am, we have predicted that less than 20% and 18% of the methylation peaks are m 6 Am peaks on the cellular transcripts in latent and lytic KSHV infected cells, respectively (Figs. 4c,5h).
We have identified a highly conserved m 6 A/m peak within the latent transcript, which contains as many as ten potentially methylated RRACH motifs during latent infection (Fig. 1) . During lytic replication, there are widespread m 6 A/m modifications on almost all viral transcripts ( Fig. 2a) , reflecting the overall expression of viral transcripts, albeit there is no correlation between an m 6 A/m peak or peak level and the actual expression level of a transcript. m 6 A/m peaks on KSHV transcripts are conserved across KiSLK and BCBL1-R cells undergoing lytic replication ( Fig. 2e ), suggesting an essential role for m 6 A/m in the KSHV lifecycle.
We show that YTHDF2 suppresses KSHV lytic replication (Fig. 3 ). Since YTHDF2 mediates the degradation and deadenylation of mRNA 20,21 , we propose that YTHDF2 might act as a cellular restriction factor of KSHV lytic replication by mediating degradation of lytic transcripts. YTHDF2 could transiently shuttle mRNA to P-bodies 20 ; however, it might also directly shuttle viral transcripts to exonucleases, deadenylases or decapping enzymes such as XRN1, PARN, CCR4-NOT or DCP1/2 for degradation in a P-body-independent mechanism. Indeed, an example of P-bodyindependent mRNA degradation occurs during KSHV lytic replication via the viral SOX protein, an endonuclease that cleaves host mRNA at specific sites and recruits the 5′ -3′ exonuclease XRN1 to complete the degradation of host mRNA 44 . Coincidently, we have observed that mRNA levels of m 6 A/m-related enzymes rapidly decline in BCBL1-R cells during KSHV lytic replication ( Supplementary Fig. 1c,d) , which could be attributed to the effect of SOX-mediated degradation 44 . Results of a microarray study also show that METTL3, WTAP, FTO, YTHDF1 and YTHDF2 are degraded during KSHV lytic replication, presumably by SOX 45 . However, we have observed more potent SOX activity in BCBL1-R than KiSLK cells ( Supplementary Fig. 1c ). It is currently unclear whether YTHDF2 and m 6 A/m modifications are involved in SOXmediated RNA degradation.
We propose that the host cells might restrict KSHV lytic replication by degrading methylated viral transcripts via YTHDF2. Alternatively, KSHV might have hijacked this host function in favouring viral latency. Recent studies showed that YTHDF1, YTHDF2 and YTHDF3 suppressed ZIKV and HCV replication but enhanced HIV-1 replication 22, [28] [29] [30] . Although we did not detect any consistent roles of other reader proteins in KSHV lytic replication, more comprehensive works are required to exclude the possibility that they might regulate different stages of viral replication. As KSHV is a large DNA virus with a complex viral replication program involving multiple stages that are regulated by many viral and cellular factors, fine-tuning of each of these stages might be necessary to ensure optimal outcomes for its lifecycle.
In cells that are latently infected by KSHV, the most apparent phenotypes are consistent 5′ UTR hypomethylation and 3′ UTR hypermethylation in all pairs of cells, except KTIME versus TIME cells ( Fig. 4e ). Of these genes, numerous pathways implicated in cellular transformation are enriched. In particular, the epithelial-mesenchymal transition (EMT) process is critical for embryogenesis and wound healing; however, KS and other cancer cells have hijacked this process to promote tumor growth, invasion, vascular extravasation and metastasis 36, 37, 46 . EMT can be induced by various stimuli including growth factors and oncogenic signalling 46, 47 . Indeed, the common enriched pathways among KMM and KMSC cells that are dynamically methylated include oncogenic pathways such as ephrin receptor signalling, ILK signalling, hypoxia signalling, BMP signalling, hepatic fibrosis and mTOR signalling, as well as pathways of remodelling of adherens junctions, Rho GTPase, Rac signalling and regulation of actin-based motility by Rho directly involved in EMT in cancer 46, 47 . Therefore, KSHV might induce cellular transformation by manipulating post-transcriptional mRNA modification. Since 5′ UTR m 6 A/m methylation has been shown to mediate translation through an eIF4E-dependent pathway 48 , whereas the 3′ UTR is preferentially targeted by miRNAs and is often enriched for m 6 A/m 3, 4 , it would be interesting to investigate how m 6 A modifications at the 5′ UTR or 3′ UTR might mediate translation and miRNA targeting of the transcripts during KSHV latency. Indeed, we have previously shown that multiple KSHV miRNAs are essential for KSHV-induced cellular transformation and tumorigenesis 49 . Examinations of KMM versus MM and KMSC versus MSC have not found any significant correlation of differential methylation in total, 3′ UTR or 5′ UTR with targets of KSHV miRNAs. It remains possible that another mechanism such as specific m 6 A/m location, secondary structure of the transcript and miRNA binding site or recruitment of other cellular proteins might be involved, which has evaded our detection.
We have observed alterations of m 6 A/m modifications in a subset of the cellular transcripts during KSHV reactivation from latency, with more de novo methylated genes observed in KiSLK cells than BCBL1-R cells (Fig. 5a ). This is not due to different sequencing depth among the samples ( Supplementary Table 8 ). Furthermore, there was a striking cell type-specific difference in the distribution of m 6 A/m on these cellular transcripts, with 5′ UTR manifesting hypermethylation in KiSLK cells and hypomethylation in BCBL1-R cells (Fig. 5d ). This differential effect could be due to the more robust SOX activity in BCBL1-R cells than KiSLK cells that might cause preferential degradation of 5′ UTR methylated transcripts ( Supplementary Fig. 1c,d) . Importantly,
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the enriched pathways that are hypermethylated in KiSLK or hypomethylated in BCBL1-R cells are highly overlapped (Fig. 5e) . First, the ubiquitin/proteasome pathway, which is hypermethylated during lytic replication, is hijacked by KSHV RTA, ORF-K3, ORF-K5 and ORF-K7 ubiquitin ligases that downregulate the host cell immune surveillance by inducing proteasomal degradation of key immune response molecules 50 . Our results suggest that hypermethylation of gene transcripts might play a role in promoting the activity of this pathway. Second, pathways including integrin, actin nucleation, PI3K/AKT, hypoxia, ERK/MAPK and ATM signalling implicated in lytic replication [38] [39] [40] [41] are both hypermethylated or hypomethylated, indicating that KSHV might deregulate these pathways by regulating m 6 A/m modifications to favour viral lytic replication.
In conclusion, as an additional layer of gene regulation at posttranscriptional level, it is not surprising that m 6 A/m is utilized by KSHV to mediate different stages of its lifecycle. Although we have established the landscape of viral and cellular m 6 A/m epitranscriptomes during KSHV latent and lytic replication, and identified novel roles of m 6 A/m in KSHV lifecycle ( Supplementary Fig. 9 ), the functions of specific m 6 A/m modifications and m 6 A/m-related factors in different stages of KSHV lifecycle, as well as how KSHV manipulates the m 6 A/m epitranscriptome to facilitate its infection and replication leading to the induction of KSHV-associated malignancies, remain to be further investigated.
Methods
Cell culture. iSLK, a renal carcinoma cell line containing a stable doxycyclineinducible cassette of RTA (ORF50), a KSHV immediate-early gene, which is essential and sufficient for activating KSHV lytic replication, was grown in HyClone DMEM supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO), 1 µ g per ml puromycin, 250 µ g per ml G418 and 1% penicillin-streptomycin. KiSLK cells derived from iSLK cells by infection with a recombinant KSHV BAC16 34 were grown as iSLK cells, except that the medium also contained 1.2 mg per ml hygromycin B. BCBL1-R, a KSHV-infected PEL cell line BCBL1 stably expressing doxycycline-inducible RTA, was grown in RPMI1640 supplemented with 10% FBS, 1% penicillin-streptomycin and 20 µ g per ml hygromycin B 35 . MSC cells, which are primary human adipose tissue-derived mesenchymal stem cells, were cultured in MSC medium (ScienCell Research Laboratories, Carlsbad, CA) containing 20% FBS, as previously described 37 . KMSC cells derived from MSC cells by infection and transformation with BAC36 32, 37 were cultured in the same media with the addition of 100 µ g per ml hygromycin B. TIME, a telomerase-immortalized human microvascular endothelial cell line, and KTIME cells derived from TIME cells by infection with BAC36, were cultured as previously described 51 . MM cells, which are primary rat metanephric mesenchymal precursor cells, and KMM cells derived from MM cells by infection and transformation with BAC36, were cultured as previously described 36 .
No further authentication of the cell lines was performed for this study. iSLK, KiSLK and BCBL1-R cells were obtained from Dr. Jae Jung. TIME cells were obtained from Dr. Don Ganem. KMM, MM, KMSC, MSC and KTIME cells were generated in our laboratory. iSLK cells were isolated from a KS lesion of an AIDS patient; however, they were later found to be of renal cell carcinoma origin. Since iSLK cells support efficient and robust KSHV lytic replication, they have been used for studying KSHV lytic replication. In this study, we employed iSLK cells to study KSHV lytic replication. iSLK, KiSLK, BCBL1-R, KMM, MM, KMSC, MSC, TIME and KTIME cells were tested for mycoplasma and showed to be negative.
KSHV lytic replication was induced in KiSLK and BCBL1-R cells by adding 1 µ g per ml doxycycline to the culture media, as previously described 34, 35 . Infectious virions, viral transcripts and proteins were examined at day 3 after induction of lytic replication unless noted otherwise.
Antibodies. Antibodies used in this study included a rabbit anti-m 6 A/m antibody (202-003, Synaptic Systems, Goettingen, Germany); a rabbit anti-human METTL3 antibody (A301-567A, Bethyl Laboratories, Inc., Montgomery, TX); a rabbit anti-human METTL14 antibody (HPA038002, Sigma); a rabbit anti-human WTAP antibody (NBP1-83040, Novus Biologicals, LLC, Littleton, CO); a mouse anti-FTO antibody (ab92821, Abcam, Cambridge, MA); a rabbit anti-ALKBH5 antibody (HPA007196, Sigma); a rabbit anti-human YTHDF1 antibody (ab99080, Abcam); a rabbit anti-human YTHDF3 antibody (ab103328, Abcam); a goat anti-mouse YTHDF3 antibody (sc-87503, Santa Cruz Inc., Dallas, TX); a rat anti-LANA antibody (ab4103, Abcam); a rabbit anti-human YTHDF2 antibody (24744-1-AP, Proteintech Group, Rosemont, IL); a mouse anti-ORFK8 antibody (sc-57889, Santa Cruz Inc.); a rabbit anti-human YTHDC1 antibody (ab133836, Abcam); a rabbit anti-human YTHDC2 antibody (ab176846, Abcam); and a mouse anti-human β -actin antibody (sc-47778, Santa Cruz Inc.). An anti-ORF57 antibody was generated by Sigma-Aldrich by immunizing a rabbit with the peptide IDGESPRFDDSIIP. The rabbit antibody to RTA and the mouse antibody to ORF65 were previously described 52, 53 .
Isolation of m 6 A/m RNA fragments. Isolation of m 6 A/m-containing fragments was performed as previously described with minor modifications 54 . Briefly, total RNA was extracted from cells using TRI Reagent (Sigma-Aldrich) followed by one round of polyA purification with Dynabeads mRNA DIRECT Kit according to manufacturers' instructions (ThermoFisher Scientific, Waltham, MA). The mRNA was fragmented in a buffer containing 100 mM Tris-HCl at pH 7.0 and 100 mM ZnCl 2 followed by incubation at 94 °C for 3 min. Successful fragmentation of mRNA with sizes close to 100 nucleotides was validated using a BioRad Experion Automated Electrophoresis Station (Bio-Rad, Hercules, CA). Before immunoprecipitation, 10 µ g of anti-m 6 A/m antibody was incubated with 30 µ l slurry of Pierce Protein A Agarose beads (ThermoFisher Scientific) by rocking in 250 µ l PBS at 4 °C for 3 h. The beads were washed three times in cold PBS followed by one wash in an immunoprecipitation (IP) buffer containing 10 mM Tris-HCl at pH 7.4, 150 mM NaCl and 1% Igepal CA-630 (Sigma-Aldrich). To isolate the m 6 A/m-containing fragments, 120 µ g of fragmented mRNA was added to the antibody-bound beads in 250 µ l IP buffer supplemented with RNasin Plus RNase inhibitor (Promega, Madison, WI), and the mixture was mixed at 4 °C for 2 h. The beads were washed seven times with 1 ml IP buffer before elution with 100 µ l IP buffer supplemented with 6.67 mM of m 6 A salt (M2780, Sigma-Aldrich). The mixture was incubated for 1 h at 4 °C and the eluate collected. A second elution was carried out and the eluates were pooled together before purification with TRI Reagent.
Preparation of m 6 A/m-seq complementary DNA library.
Purified eluate and input samples were used for preparation of libraries and sequencing at the Genome Sequencing Facility at the Greehey Children's Cancer Research Institute at the University of Texas Health Science Center at San Antonio. Approximately 10-25 ng of mRNA was used for RNA sequencing (RNA-seq) library preparation using the TruSeq stranded mRNA kit (Illumina, San Diego, CA) according to manufacturer's protocol with two modifications. First, the elute-frag-prime stage was done at 80 °C for 2 min to allow annealing without causing fragmentation. RNA was reverse transcribed into first strand cDNA using reverse transcriptase and random primers. This was followed by the second strand cDNA synthesis using DNA Polymerase I and RNase H. The cDNA fragments then went through an end repair process with the addition of a single ' A' base followed by ligation of adapters. The products were then purified and enriched by PCR amplification for ten cycles to generate the final RNA-seq library. The second modification was done to adjust the bead/ DNA ratio to preserve smaller fragments during the adapter ligation double beads clean-up step. A beads/DNA ratio of 1:3 instead of 1:1 was used. cDNA libraries were quantified and pooled for cBot amplification and subsequent sequencing on an Illumina HiSeq 2000 platform 50 bp single read sequencing module. After the sequencing run, demultiplexing with CASAVA was employed to generate a fastq file for each sample.
Genome annotation. For KSHV BAC36 and BAC16 genomes, we collected annotation information from previous studies of RNA-seq, 5′ and 3′ rapid amplification of cDNA ends and transcript isoform mapping to generate a comprehensive annotation of viral transcripts [55] [56] [57] [58] [59] [60] . UCSC hg19 and rn5 reference genomes of human and rat, and annotation files, were downloaded from Illumina iGenome. m 6 A/m-seq data analysis. Reads of the IP/Input samples were aligned to the corresponding genomes using Tophat2 Aligner v2.0.6, which implicitly calls Bowtie2 with default options 61, 62 . Following this, peak calling and differential m 6 A/m methylation analyses were performed using the exomePeak R/Bioconductor package, a software specifically designed for m 6 A-seq data analysis 33, 63 . The peak calling is based on the Przyborowski and Wilenski method for comparing the means of two Poisson distributions (C-test) 64 , which computes the methylation enrichment of normalized IP reads over normalized input reads (or mRNA abundance) as the test statistics. Only the loci that show significant methylation enrichment are determined as peak regions. For differential m 6 A/m analysis, the fold changes of methylation enrichments between two conditions are calculated and a rescaled hypergeometric test is applied to determine the significance of differential fold enrichment. The output of exomePeak includes the loci of the (differential) m 6 A/m peaks, the gene symbol of the transcripts to which peaks localize, the detection P values, false discovery rates (FDR) and methylation enrichment (for peak calling) or enrichment fold-change (for differential m 6 A/m analysis). For both m 6 A/m peak calling and differential peak discovery, an FDR threshold of 0.05 is used. m 6 A/m peaks were annotated with identifiers such as Gene Symbol and RefSeq ID as well as regional overlapping status (5′ UTR/coding DNA sequence/3′ UTR). Regional distribution of m 6 A/m was plotted using the Guitar package 65 . Motif analysis of m 6 A/m peaks was performed using the MEME package 66 .
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The m 6 A/m-seq technology cannot measure the stoichiometry of m 6 A/m methylation and the predicted peaks could have low stoichiometry. However, exomePeak predicts m 6 A/m peaks based on their enrichment of IP reads over input reads. Although this enrichment cannot directly estimate the stoichiometry, it preserves, to some extent, the relationship of the stoichiometry between different sites. That is, the higher the enrichment, the larger the stoichiometry the predicted site is likely to have. As a result, the significant peaks predicted by exomePeak are likely to have relatively higher stoichiometry. Nevertheless, because of the experimental and modelling noise, there is always a chance that the predicted peaks might have low stoichiometry. m 6 Am analysis. Using the m 6 A/m-seq datasets, we predicted m 6 Am sites as ' A's that locate at the beginning of RefSeq-annotated transcripts, contain the BCA motif 5 and are inside the exomePeak-predicted peaks. If a peak was mapped to a RefSeq transcript with multiple transcript start sites, only the ' A' that is closest to the peak centre was predicted as an m 6 Am site. Because of the limitation of m 6 A/m-seq, these predicted m 6 Am sites are only putative m 6 Am sites in the transcriptome and this method would miss the true m 6 Am sites without the BCA motifs. Furthermore, the predicted results could change if a different transcript annotation system is used.
Clustering analysis. To investigate the methylation behaviour of genes across samples, the highest fold enrichment among all peaks within a gene was considered as the methylation fold enrichment of the gene. Hierarchical clustering with Euclidean distance was used to group similarly methylated genes according to sample.
Gene expression analysis. The expression of transcripts and isoforms and differential expression levels were calculated using cufflinks and cuffdiff, respectively, based on the input samples 67, 68 . To avoid underestimating the expression of viral genes during lytic replication, we used reads mapped to both cellular and viral genomes to calculate the fragments per kilobase of transcript per million mapped reads (FPKM). All the other bioinformatics analyses were performed on Matlab, R or Perl. siRNA knockdown. siRNA silencing was performed by transfecting 2.5 pmol of each siRNA per well in a 12-well plate into the KiSLK cells using Lipofectamine RNAi Max according to manufacturer's instructions (ThermoFisher Scientific). Two days after transfection, the cells were monitored for knockdown efficiency of the target gene by RT-qPCR and western blotting, and induced for lytic replication with 1 µ g per ml of doxycycline. siRNAs were purchased from Sigma-Aldrich. Their product numbers and sequences are as follows. YTHDF1 si1: SASI_Hs01_00233686 (5′ -CAGAGCUCCGCGUAUGGGA-3′ ); YTHDF1 si2: SASI_Hs01_00233688 (5′ -GUCAAUGGGAGUGGGCAUU-3′ ); YTHDF1 si3: SASI_Hs01_00233689 (5′ -GAAACGCGGCGUUUGGGCA-3′ ); YTHDF2 si1: SASI_Hs01_00133215 (5′ -GUUCCAUUAAGUAUAAUAU-3′ ); YTHDF2 si2: SASI_Hs01_00133214 (5′ -CUGCUUAUCGUUCCAUGAA-3′ ); YTHDF3 si1: SASI_Hs01_00202277 (5′ -CAAACCUCAACCGAAACUU-3′ ); YTHDF3 si2: SASI_Hs01_00202278 (5′ -CAAUUCAAGGGACACUCAA-3′ ); YTHDC1 si1 SASI_Hs01_00115890 (5′ -CUUGUAUCAGGUCAUUCAU-3′ ); YTHDC1 si2 SASI_Hs01_00363062 (5′ -GUGAUGGACAGGAAAUUGA-3′ ); YTHDC2 si1 SASI_Hs01_00161045 (5′ -CAACUUAGAGCAUCAGGUU-3′ ); YTHDC2 si2 SASI_Hs01_00161046 (5′ -GCCUAUUUAUAACCACUGA-3′ ); and siControl (siCl): Sigma siRNA Universal Negative Control #1 (SIC001-10NMOL).
RT-qPCR for gene expression and MeRIP-qPCR for m 6 A/m-seq validation.
Total RNA was isolated with TRI Reagent according to the manufacturer's protocol. Reverse transcription was performed with 1 µ g of total RNA using Maxima H Minus First Strand cDNA Synthesis Kit (Cat. # K1652, ThermoFisher Scientific). Quantitative PCR was done using SsoAdvanced Universal SYBR Green Supermix (BioRad) and analysed with a CFX Connect Real-Time PCR Detection System (BioRad). Relative gene expression levels were obtained by normalizing the cycle threshold (CT) values to those of 18 S to yield 2 -ΔΔCt values. For validation of m 6 A/m-seq, 5 ng of eluate or input mRNA was subjected to RT-qPCR. Fold enrichment was calculated by calculating the 2 -ΔCt of eluate relative to the input sample. The primers used for gene expression are: ATCAACTTTCGATGGTAGTCG (forward) and TCCTTGGATGTGGTAGCCG (reverse) for human 18 S; CATTCGAACGTCTGCCCTAT (forward) and GTTTCTCAGGCTCCCTCTCC (reverse) for rat 18 S; CGACAGCGCTGGAATCCTAT (forward) and GCCATCAAGGGATCCACTCC (reverse) for human SON; GCAAGAAGGTAGGGGTCATGT (forward) and AGGGGTAAATCCCTGTCAAACA (reverse) for human METTL3; GATAGCCGCTTGCAGGAGAT (forward) and ACTTTCAGCTCCCAACTGCT (reverse) for human METTL14; ATCAGGCAAGTGAAAGCCTCA (forward) and GTCCAGGATGACCTTATGGGTT (reverse) for human WTAP; GTGGAGACTTCTCTTGGCCC (forward) and GGGCACCATTTCCTAGCTGT (reverse) for human FTO; TCAAGCCTATTCGGGTGTCG (forward) and ATCCACTGAGCACAGTCACG (reverse) for human ALKBH5; CTCAATGAGCGACCCCTACC (forward) and AGTAGACCACGGAGCCTCAT (reverse) for human YTHDF1; TGTTGGAGAAGCTTCGGTCC (forward) and ACCCGGCCATGTTTCAGATT (reverse) for human YTHDF2;
NATURe MicRObiOlOgY tissue culture dish. Once 80% confluent, lytic replication was induced with 1 µ g per ml doxycycline for 48 h. Cells were lysed with lysis buffer containing 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA and 1% Igepal CA-630 for 20 min at 4 °C. A fraction of the lysate (10%) was saved as input. The cell lysate was incubated with mouse anti-flag M2 beads (Sigma-Aldrich) overnight. The next day, the beads were washed five times with lysis buffer and RNA was collected by adding TRI Reagent to the beads. Input lysate (1%) and all the immunoprecipitated RNA were used for RT-qPCR.
Pathway analysis. Significantly differentially methylated genes were identified by applying an FDR (log10 FDR) filter of < -1.3, and enriched pathways were determined using the default settings of QIAGEN's Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity). Comparison analysis was done by sorting the P values of the commonly enriched pathways by score.
Statistical analyses.
All the experiments were independently performed at least three times, unless stated otherwise, and the results were analysed and presented. Student's t-test was used for RT-qPCR, MeRIP-qPCR, RIP-PCR and western blotting band intensity analyses in Microsoft Excel. Transcript half-life was calculated using one phase decay nonlinear regression and the significance between the decay curves was determined using the Wilcoxon signed-rank test in GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA). The Mann-Whitney test was used to calculate the significance of curves of half-lives of transcripts with and without YTHDF2 knockdown. In all results, NS denotes 'not significant' , *P < 0.05, **P < 0.01 and ***P < 0.001.
Life Sciences Reporting Summary. Further information on experimental design and reagents is available in the Life Sciences Reporting Summary.
Data availability.
Sequencing data that support the findings of this study have been deposited in GEO with the accession code GSE93676.
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Replication
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All replication attempts were successful.
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No randomization done for these experiments.
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Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
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Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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